Finance

Beta
Lists
300199:SHE
Hybio Pharmaceutical Co Ltd
CNÂ¥22.75
-3.19%
(-0.75) 1D
May 21, 3:04:13 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300199...
Open
CNÂ¥23.55
High
CNÂ¥24.00
Low
CNÂ¥22.68
Mkt. cap
20.76B
Avg. vol.
55.90M
Volume
45.85M
P/E ratio
212.60
52-wk high
CNÂ¥31.19
52-wk low
CNÂ¥13.46
EPS
CNÂ¥0.11
Shares outstanding
883.24M
No. of employees
1K
News stories
From sources across the web
About Hybio Pharmaceutical Co Ltd
CEO-
Employees1.23K
Founded1998
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
239.47M
133.68M
283.23M
299.15M
Cost of goods sold
81.57M
64.65M
152.93M
105.01M
Cost of revenue
81.57M
64.65M
152.93M
105.01M
Research and development expenses
24.48M
27.93M
51.07M
30.87M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
40.23M
72.08M
59.40M
44.68M
Operating expense
66.61M
100.98M
121.55M
80.50M
Total operating expenses
148.17M
165.63M
274.48M
185.52M
Operating income
91.30M
-31.95M
8.75M
113.63M
Other non operating income
-3.50M
-8.30M
-4.72M
-3.55M
EBT including unusual items
83.61M
-72.35M
-23.38M
136.89M
EBT excluding unusual items
65.41M
-62.66M
-21.32M
134.01M
Income tax expense
8.53M
2.41M
12.35M
9.50M
Effective tax rate
10.21%
-3.34%
-52.81%
6.94%
Other operating expenses
3.44M
3.09M
4.18M
1.78M
Net income
75.60M
-74.12M
-34.78M
127.81M
Net profit margin
31.57%
-55.44%
-12.28%
42.73%
Earnings per share
-
-
-
-
Interest and investment income
1.03M
2.00M
-
224.45K
Interest expense
-25.27M
-22.57M
-26.19M
-23.28M
Net interest expenses
-24.24M
-20.56M
-26.19M
-23.05M
Depreciation and amortization charges
-
-
-
-
EBITDA
124.10M
4.53M
41.34M
146.22M
Gain or loss from assets sale
-552.48K
552.48K
-617.19K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more